Why is Biogen Pharma falling/rising?

As of 07-Oct, Biogen Pharmachem Industries Ltd is experiencing a price increase, with its current price at 0.88, reflecting a change of 0.04 or 4.76% upwards. The stock has shown a performance today that outperformed its sector by 6.24%. In terms of returns, over the past week, the stock has increased by 6.02, while it has seen a decline of 1.12% over the past month and a significant drop of 25.42% year-to-date. Despite these longer-term declines, the recent rise in delivery volume, which increased by 4.21% against the 5-day average, indicates a growing interest among investors, contributing positively to the stock's recent upward movement. Unfortunately, there is no specific information available regarding positive or negative factors impacting the stock.
Broader market context shows that while Biogen's short-term performance has been strong, with a 6.02% increase over the past week, it has still lagged behind the benchmark Sensex, which rose by 2.07% during the same period. This indicates that the stock's recent gains are notable compared to its historical performance and the broader market, suggesting a potential recovery phase. However, the stock's year-to-date and one-year returns remain significantly negative, highlighting ongoing challenges despite the recent uptick.